Zero Point Five Therapeutics, Inc.

New Filing
CIK: 0001985295·Biotechnology·DISTRICT OF COLUMBIA·Filed: Apr 17, 2025
Total Offering

$5,333,250

Amount Sold

$4,299,420

Investors

10

First Sale

Apr 2, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Joseph Amprey III
Related Person
Ben Auspitz
Related Person
Jodi Jahic
Related Person

Company

Zero Point Five Therapeutics, Inc.

915 S. EATON STREET

BALTIMORE, MD, 21224

301-327-0118

SEC Filing

0002054934-25-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Zero Point Five Therapeutics, Inc. Form D Filing — $5,333,250 | FilingFlow